Dana Monroe

Dana Monroe serves as a key procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical solutions for infectious, immunologic, and allergic diseases. Responsible for managing complex acquisitions in laboratory infrastructure and high-containment research capabilities, Monroe oversees contracts for critical medical countermeasures, diagnostic tools, and biosafety equipment. Their work directly enables NIAID’s response to emerging public health threats by ensuring timely access to advanced scientific resources and specialized services essential for mission-critical research. Monroe maintains strategic relationships with a focused set of contractors, including Quality Biological, Inc., a leading provider of biological reference materials, and Genomic Labs Ltd., which delivers advanced genomic analysis services. These partnerships reflect a preference for vendors with proven expertise in high-containment bioscience, analytical instrumentation, and biological product manufacturing. The contracting approach emphasizes reliability, regulatory compliance, and technical precision, favoring established suppliers with deep domain knowledge in infectious disease research environments. Monroe’s procurement portfolio reflects no set-aside preferences, with 100% of awards issued under full and open competition. This pattern indicates a priority on technical capability and operational readiness over socioeconomic classifications, aligning with NIAID’s urgent need for specialized, high-integrity scientific services and products that meet stringent biosafety and quality standards. The primary NAICS focus areas include analytical laboratory instrument manufacturing (334516), testing laboratory services (541380), and biological product manufacturing (325414), underscoring expertise in procuring precision instruments, diagnostic testing infrastructure, and research-grade biological reagents. Monroe’s technical domain centers on supporting BSL-3 and BSL-4 research environments, with consistent demand for equipment maintenance (811210) and specialized laboratory services critical to infectious disease surveillance and therapeutic development.